(Q38474301)

English

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

scientific article published on 12 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

0 references

1 reference

Europe PubMed Central

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis (English)

1 reference

Europe PubMed Central

3 September 2017

0 references

inflammatory bowel diseases

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mahmoud H. Mosli

1

0 references

William Jeffery Sandborn

7

object named as

William J Sandborn

1 reference

Europe PubMed Central

3 September 2017

Brian G. Feagan

8

object named as

Brian G Feagan

1 reference

Europe PubMed Central

3 September 2017

2

object named as

Guangyong Zou

1 reference

Europe PubMed Central

3 September 2017

6

object named as

Nilesh Chande

1 reference

Europe PubMed Central

3 September 2017

author name string

Sushil K Garg

3

1 reference

Europe PubMed Central

3 September 2017

Sean G Feagan

4

1 reference

Europe PubMed Central

3 September 2017

John K MacDonald

5

1 reference

Europe PubMed Central

3 September 2017

language of work or name

0 references

publication date

12 May 2015

1 reference

Europe PubMed Central

3 September 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

3 September 2017

110

1 reference

Europe PubMed Central

3 September 2017

6

1 reference

Europe PubMed Central

3 September 2017

802-19; quiz 820

1 reference

Europe PubMed Central

3 September 2017

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Diagnostic yield of colonoscopy based on symptoms

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein Level

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Enzymes in feces: useful markers of chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

A simple method for assessing intestinal inflammation in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Meta-analysis of diagnostic studies: a comparison of random intercept, normal-normal, and binomial-normal bivariate summary ROC approaches

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Diagnostic Value of C-Reactive Protein for Predicting Activity Level of Crohn’s Disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

C-reactive protein and monitoring the activity of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

C-reactive protein across the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Predicting outcome in severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Reply: budesonide

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.120

21 January 2018

Clinical relevance of circulating midkine in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Scintigraphy using leukocytes marked with 99m-Tc-HMPAO in Crohn's disease]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical perspectives in Crohn's disease. Objective measures of disease activity: alternatives to symptom indices.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colonoscopic perforations: incidence, management, and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of disease location on fecal calprotectin levels in Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indium-111-labeled autologous leukocyte imaging and fecal excretion. Comparison with conventional methods of assessment of inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Faecal calprotectin: a marker of inflammation throughout the intestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentrations of pancreatic secretory trypsin inhibitor (PSTI), acute phase proteins, and neopterin in Crohn's disease. Comparison with clinical disease activity and endoscopical findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2015.120

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38474301&oldid=1761352582"